Breaking News Instant updates and real-time market news.

AMRN

Amarin

$21.28

0.77 (3.75%)

06:07
12/02/19
12/02
06:07
12/02/19
06:07

Amarin: EMA validates marketing authorization application for Vascepa

Amarin announced that the European Medicines Agency has validated the marketing authorization application seeking approval for icosapent ethyl (brand name Vascepa in the United States) as a treatment to reduce the risk of cardiovascular events in high-risk patients who have their cholesterol levels controlled with statin treatment, but have elevated triglycerides,135 mg/dL or above, and other cardiovascular risk factors. The validation confirms the submission for Vascepa is sufficiently complete for the EMA to begin its review procedure, which is currently expected to be completed before the end of 2020.

  • 28

    Dec

AMRN Amarin
$21.28

0.77 (3.75%)

11/19/19
OPCO
11/19/19
INITIATION
Target $7
OPCO
Underperform
Oppenheimer starts Amarin with $7 target on 'rich' valuation, 'stale' M&A thesis
Oppenheimer analyst Leland Gershell initiated coverage of Amarin with an Underperform rating and $7 price target. The stock closed Tuesday up 13c to $22.73. Amarin's current valuation reflects expectations that, following near-term label expansion of sole omega-3 product Vascepa, the company's sales will inflect and grow to $2B-plus by 2024 and its operating margins will meaningfully improve, Gershell tells investors in a research note. The analyst, however, forecasts Amarin's sales growth to "underwhelm" and that "heavy selling costs" will impede its profitability. Furthermore, a 12-month stream of late-stage competitor data starting next month will increasingly weigh on shares as these products will offer superior profiles, adds Gershell. In addition, the analyst thinks the likelihood of Amarin getting acquired will only shrink with time. He views Amarin's valuation as "rich" and the M&A thesis as "stale."
11/20/19
SBSH
11/20/19
NO CHANGE
Target $16
SBSH
Neutral
Citi prefers Amarin shares to The Medicines Co. after this week's divergence
Amarin (AMRN) shares this week have declined 5% while The Medicines Co. (MDCO) stock is up 35%, Citi analyst Joel Beatty tells investors in a research note. This has brought The Medicines Co.'s enterprise value to $7.5B, exceeding Amarin's enterprise value of $7.4B, the analyst points out. However, he does not see anything fundamental having changed that would support this "drastic of a change in the relative valuation of the two companies." Thus, while Beatty keeps a Neutral rating on both stocks, he prefers owning Amarin over The Medicines Co. at this time. The Medicines Co. now looks expensive relative to Amarin, he contends. Further, the analyst says that Bloomberg's report this week of Novartis (NVS) having expressed interest in The Medicines Co. does not provide new evidence that the company is attractive from a valuation standpoint to potential acquirers.
11/22/19
JEFF
11/22/19
NO CHANGE
JEFF
Buy
Amarin recent pullback a buying opportunity, says Jefferies
Jefferies analyst Michael Yee recommends using the recent pullback in shares of Amarin as a buying opportunity. Following a meeting with management, the analyst sees confidence around a good label for Vascepa that is broader than just primary prevention. Yee expects a "strong" 2020 launch, pointing out that Amarin has doubled its salesforce and are launching direct-to-consumer. In addition, Amarin could reach a patent settlement or end up winning the trial, says Yee, who keeps a Buy rating on the shares.
11/25/19
AGIS
11/25/19
NO CHANGE
Target $23
AGIS
Buy
Amarin's Vascepa 'well on the way to becoming a blockbuster,' says Aegis
Aegis analyst Nathan Weinstein said in a note to investors on Friday that he believes Amarin's Vascepa is "well on the way to becoming a blockbuster drug," meaning one that can achieve greater than $1B in annual sales, and he thinks the drug "should achieve peak sales significantly above that." In what he views as a "conservative base case" where the drug is approved for secondary prevention along with additional patient qualifications, Weinstein predicts Vascepa could achieve sales "north of $2B a year" by 2025, Weinstein told investors. He kept a Buy rating and $23 price target on Amarin shares.

TODAY'S FREE FLY STORIES

CFRX

ContraFect

$0.30

-0.038 (-11.41%)

09:21
12/10/19
12/10
09:21
12/10/19
09:21
Syndicate
ContraFect 37.15M share Spot Secondary priced at 27c »

Maxim acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

JNJ

Johnson & Johnson

$140.51

0.15 (0.11%)

09:20
12/10/19
12/10
09:20
12/10/19
09:20
Earnings
Janssen says Phase 3 CANDOR study met primary endpoint »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

EPAY

Bottomline Technologies

$47.88

0.38 (0.80%)

09:18
12/10/19
12/10
09:18
12/10/19
09:18
Conference/Events
Bottomline Technologies management to meet with Craig-Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 19

    Feb

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
12/10/19
12/10
09:18
12/10/19
09:18
Options
Overnight activity included 1216 trades in SPX and 10 trades in VIX »

1216 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHWY

Chewy

$24.17

-0.76 (-3.05%)

09:16
12/10/19
12/10
09:16
12/10/19
09:16
Recommendations
Chewy analyst commentary  »

Chewy price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

DBI

Designer Brands

$17.01

0.39 (2.35%)

09:15
12/10/19
12/10
09:15
12/10/19
09:15
Hot Stocks
Designer Brands says ability to mitigate 100% of tariffs is not likely »

Says gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

09:14
12/10/19
12/10
09:14
12/10/19
09:14
General news
House Democrats announce two articles of impeachment against President Trump »

House Democrats announced…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$313.89

-0.93 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$31.82

0.645 (2.07%)

, VZ

Verizon

$61.00

-0.19 (-0.31%)

09:11
12/10/19
12/10
09:11
12/10/19
09:11
Hot Stocks
Avis Budget announces partnership with Verizon for digital travel assistants »

Avis Budget (CAR), in…

CAR

Avis Budget

$31.82

0.645 (2.07%)

VZ

Verizon

$61.00

-0.19 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 30

    Jan

DSX

Diana Shipping

$3.37

-0.01 (-0.30%)

09:11
12/10/19
12/10
09:11
12/10/19
09:11
Conference/Events
Diana Shipping management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

OMCL

Omnicell

$80.03

-1.7 (-2.08%)

09:10
12/10/19
12/10
09:10
12/10/19
09:10
Earnings
Breaking Earnings news story on Omnicell »

Omnicell sets FY24…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

09:10
12/10/19
12/10
09:10
12/10/19
09:10
General news
Treasury Action: yields have risen in response to the trade news »

Treasury Action: yields…

LLNW

Limelight Networks

$4.28

0.125 (3.01%)

09:09
12/10/19
12/10
09:09
12/10/19
09:09
Earnings
Limelight Networks sees FY20 EPS 0c-10c, consensus 8c »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THO

Thor Industries

$64.28

-3.485 (-5.14%)

09:06
12/10/19
12/10
09:06
12/10/19
09:06
Recommendations
Thor Industries analyst commentary  »

Thor Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

NFLX

Netflix

$302.48

-4.88 (-1.59%)

, NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

09:06
12/10/19
12/10
09:06
12/10/19
09:06
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Genworth (GNW),…

NFLX

Netflix

$302.48

-4.88 (-1.59%)

NLOK

NortonLifeLock

$25.43

-0.02 (-0.08%)

INTC

Intel

$56.52

-0.28 (-0.49%)

GNW

Genworth

$4.17

0.03 (0.72%)

AZO

AutoZone

$1,171.30

-0.78 (-0.07%)

SFIX

Stitch Fix

$25.17

1.04 (4.31%)

MDB

MongoDB

$131.03

-0.19 (-0.14%)

DBI

Designer Brands

$17.01

0.39 (2.35%)

CONN

Conn's

$20.51

1.08 (5.56%)

CHWY

Chewy

$24.17

-0.76 (-3.05%)

CNST

Constellation Pharmaceuticals

$36.15

-7.95 (-18.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 19

    Dec

  • 19

    Dec

  • 23

    Jan

  • 11

    Dec

CMTL

Comtech

$34.70

-0.41 (-1.17%)

09:06
12/10/19
12/10
09:06
12/10/19
09:06
Hot Stocks
Comtech receives $1.3M contract for military communications amplifiers »

Comtech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXNX

Axonics

$24.32

-1.22 (-4.78%)

, MDT

Medtronic

$111.12

-2.02 (-1.79%)

09:02
12/10/19
12/10
09:02
12/10/19
09:02
Recommendations
Axonics, Medtronic analyst commentary  »

Morgan Stanley raises…

AXNX

Axonics

$24.32

-1.22 (-4.78%)

MDT

Medtronic

$111.12

-2.02 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

DNOW

NOW Inc.

$11.12

-0.3 (-2.63%)

09:01
12/10/19
12/10
09:01
12/10/19
09:01
Conference/Events
NOW Inc. management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

  • 19

    Feb

RL

Ralph Lauren

$113.26

1.62 (1.45%)

09:00
12/10/19
12/10
09:00
12/10/19
09:00
Conference/Events
Ralph Lauren management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

09:00
12/10/19
12/10
09:00
12/10/19
09:00
General news
U.S. equities are firmer »

U.S. equities are firmer,…

SLB

Schlumberger

$37.16

0.28 (0.76%)

08:59
12/10/19
12/10
08:59
12/10/19
08:59
Hot Stocks
Schlumberger appoints Stephane Biguet as CFO, effective January 22 »

Schlumberger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

CRAI

CRA International

$52.40

-0.08 (-0.15%)

08:57
12/10/19
12/10
08:57
12/10/19
08:57
Conference/Events
CRA International management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

DHR

Danaher

$147.51

-0.66 (-0.45%)

, PCG

PG&E

$11.05

1.4 (14.51%)

08:55
12/10/19
12/10
08:55
12/10/19
08:55
Options
Notable open interest changes for December 10th »

Monday's total…

DHR

Danaher

$147.51

-0.66 (-0.45%)

PCG

PG&E

$11.05

1.4 (14.51%)

AAPL

Apple

$266.93

-3.75 (-1.39%)

AMD

AMD

$38.91

-0.7 (-1.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 07

    Jan

08:55
12/10/19
12/10
08:55
12/10/19
08:55
General news
The U.S. productivity report »

The U.S. productivity…

MDB

MongoDB

$131.03

-0.19 (-0.14%)

08:54
12/10/19
12/10
08:54
12/10/19
08:54
Recommendations
MongoDB analyst commentary  »

MongoDB price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 18

    Dec

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

, TGT

Target

$126.43

1.4 (1.12%)

08:54
12/10/19
12/10
08:54
12/10/19
08:54
Recommendations
Amazon.com, Target, Walmart analyst commentary  »

Amazon one-day offerings…

AMZN

Amazon.com

$1,749.61

-1.18 (-0.07%)

TGT

Target

$126.43

1.4 (1.12%)

WMT

Walmart

$119.34

-0.43 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.